Lipocine Inc.
Net BuyingLPCN·US·🇺🇸 US
65%buys·35%sells
186 transactions$486KTotal buys·26 buys
$215KTotal sells·14 sells
1414 insiders
Last: Apr 2, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 7, 26 | Higuchi John W. | Buy | $81K | |
| Apr 6, 26 | Higuchi John W. | Buy | $252K | |
| Apr 6, 26 | Patel Mahesh V. | Buy | $51K | |
| Apr 2, 26 | Patel Mahesh V. | Buy | $51K | |
| Dec 18, 25 | Fogarty Krista | Grant | $87K | |
| Dec 18, 25 | Patel Mahesh V. | Grant | $36K | |
| Jun 4, 25 | Ono Richard Dana | Grant | $6K | |
| Jun 4, 25 | Higuchi John W. | Grant | $6K | |
| Jun 4, 25 | Jene Jill M. | Grant | $6K | |
| Jun 4, 25 | Papapetropoulos Spyridon | Grant | $6K |
Patel Mahesh V. (CEO) recently executed a buy of $51K in Lipocine Inc. shares on April 6, 2026. Overall insider sentiment is bullish (65% purchases).
Lipocine Inc. (LPCN) has recorded 186 insider operations, including 26 open-market purchases ($486K), 14 sales ($215K) and 146 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (65% purchases).
Recent activity is concentrated over 3 months in the last year.
Among the most active insiders are Patel Mahesh V. (CEO), BROWN MORGAN R (CFO) & Mattila Jyrki (C SUITE), with respectively 61, 48, 50 transactions.
Across all 189 recorded transactions, the breakdown by type is: grant (107, 57%), exercise (38, 20%), buys (29, 15%), sells (14, 7%), other (1, 1%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Lipocine Inc. has recorded 186 insider operations in total, including 26 open-market purchases ($486K), 14 sales ($215K) and 146 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 2, 2026.
Insiders at Lipocine Inc. are currently net buyers, with 65% purchases and 35% sales across all reported transactions. Total buy volume is $486K versus $215K in sales, indicating a bullish insider sentiment.
InsiderLens tracks 14 insiders at Lipocine Inc. (LPCN). Patel Mahesh V. (CEO, 61 tx), BROWN MORGAN R (CFO, 48 tx), Mattila Jyrki (C SUITE, 50 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for LPCN is bullish, based on a 65% buy ratio across 40 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Lipocine Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.